Products with Anticancer bioactivity
| Cat.No. | Product Name |
|---|---|
| BCN3757 | Viniferin |
| 1. α-Viniferin has anti-oxidant and anticancer activities. 2. ɛ-Viniferin and vincristine can enhance the anti-tumor effects efficiently by inducing HepG2 cell apoptosis. 3. α-Viniferin strongly inhibits the activities of the two CYPs dose dependently. 4. α-Viniferin suppresses the expression of proinflammatory genes iNOS and COX-2 in the early stage of inflammation by inhibiting the Akt/PI3K-dependent NF-κB activation and inhibits the production of proinflammatory mediators NO and PGE2 in the late stage by stimulating Nrf2-mediated HO-1 signaling pathway in LPS-stimulated BV2 microglial cells. | |
| BCN3764 | Kansuiphorin C |
| 1. Kansuiphorin C shows cytotoxic activity. | |
| BCN3765 | Kansuinine A |
| 1. Kansuinine A possesses analgesic props. 2. Kansuinine A shows NGF inducing activity. | |
| BCN3766 | Kansuinine B |
| 1. Kansuinine B shows cytotoxic activity. 2. Kansuinine B shows analgesic activity. 3. Treatment with kansuinine B and kansuinine A represents a novel method to block the IL-6-induced effects. | |
| BCN3771 | Jolkinolide A |
| Jolkinolide A has anti-tumor activity. It inhibited VEGF expression in A549 cells through the inhibition of the Akt-STAT3-mTOR signaling pathway, and directly inhibited the proliferation and migration of HUVECs. | |
